| http://www.w3.org/ns/prov#value | - When the STRIDE-PD trial was removed from the analysis, the relative risk was 1.67 (95% Confidence Interval: 0.77, 3.61), i.e., a finding that was no longer statistically significant.Although there was a statistically significant increased risk of cardiovascular events in the entacapone/carbidopa/levodopa group compared to carbidopa/levodopa group when STRIDE-PD is included, the following factors
|
